Internal Medicine, Rheumatology · Tomball, TX
NPI
1629026273
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
455 School St, Suite 27
Tomball, TX, 77375
Phone (281) 357-0666
Groups this clinician bills Medicare through
Medicare paid, 2024
$848K
140,054 services
Medicare patients, 2024
323
Average age 74
Drug cost, 2024
$5.9M
7,562 prescriptions
Company payments, 2025
$3,185
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shaikh Ali was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 115,600 times for 32 patients. In total Shaikh Ali billed 140,054 services in 39 codes, and Medicare paid $848K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-05-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 115,600 | 32 | $3.60 | $416K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,600 | 49 | $0.09 | $527 |
| J0897 Injection, denosumab, 1 mg | Office | 2,580 | 29 | $20.33 | $52K |
| 96401 Chemotherapy Administration | Office | 625 | 62 | $59.80 | $37K |
| 99213 Office E&M - Established | Office | 580 | 271 | $65.05 | $38K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 257 | 182 | $12.84 | $3,300 |
| J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 149 | 13 | $53.41 | $7,958 |
| 96413 Chemotherapy Administration | Office | 125 | 20 | $107.32 | $13K |
| 36415 Venipuncture Blood Collection | Office | 124 | 23 | $8.65 | $1,073 |
| 20610 Joint Injection | Office | 123 | 38 | $72.15 | $8,875 |
| 99212 Office E&M - Established | Office | 79 | 57 | $39.17 | $3,094 |
| 77080 Standard X-ray | Office | 75 | 75 | $40.61 | $3,046 |
| 96372 Injection Administration | Office | 71 | 49 | $9.18 | $652 |
| 99214 Office E&M - Established | Office | 63 | 53 | $95.14 | $5,994 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 33 | 29 | $4.42 | $146 |
By year: 2022 $1.0M for 122,607 services; 2023 $844K for 122,542 services; 2024 $848K for 140,054 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 124 | 23 | $8.65 | $1,073 |
Medicare prescription drug claims, 2024
In 2024, the drug Shaikh Ali prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,051 prescriptions and refills. In total Shaikh Ali wrote 7,562 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,051 | 2,299 | 289 | $26K |
| Prednisone Generic | 824 | 1,342 | 241 | $4,220 |
| Leflunomide Generic | 740 | 1,464 | 197 | $41K |
| Alendronate Sodium Generic | 399 | 1,011 | 141 | $2,746 |
| Hydroxychloroquine Sulfate Generic | 351 | 662 | 97 | $11K |
| Tramadol Hcl Generic | 268 | 269 | 56 | $1,518 |
| Enbrel Sureclick Etanercept | 265 | 291 | 32 | $2.2M |
| Folic Acid Generic | 210 | 576 | 74 | $1,293 |
| Gabapentin Generic | 205 | 337 | 62 | $3,036 |
| Celecoxib Generic | 197 | 322 | 58 | $4,992 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 141 | 141 | 26 | $3,241 |
| Cyclobenzaprine Hcl Generic | 118 | 187 | 37 | $1,264 |
| Meloxicam Generic | 100 | 210 | 35 | $598 |
| Humira(Cf) Pen Adalimumab | 98 | 108 | 15 | $855K |
| Allopurinol Generic | 98 | 254 | 29 | $1,124 |
Brand drugs: - claims; generic drugs: 6,360 claims; opioid claims: 410.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shaikh Ali $3,185 ($3,185 in general payments such as food, travel and fees) from 20 companies. The largest payer was Amgen Inc. with $792.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 40 | $792 |
| Abbvie Inc. ABBV | 37 | $726 |
| UCB, Inc. UCB.BR | 15 | $480 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $217 |
| GlaxoSmithKline, LLC. GSK | 12 | $192 |
| Pfizer Inc. PFE | 11 | $170 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $166 |
| ANI Pharmaceuticals, Inc. ANIP | 6 | $114 |
| Janssen Biotech, Inc. JNJ | 4 | $83.4 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $81.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.